Kyle Fogarty is a founder and clinical research leader with deep experience across clinical trials, healthcare, and medical education. He is the founder of Polus Health, where he focuses on accelerating clinical trial enrollment and improving site performance across therapeutic areas, including retina and ophthalmology.
Kyle has grown Polus Health from the ground up, working across sponsor, CRO, and site environments to streamline operations and drive measurable improvements in study execution. Prior to founding Polus, he led initiatives to enhance patient screening, optimize investigational product utilization, and oversee staff training and site operations.
Earlier in his career, Kyle played a key role at Case Western Reserve University, leading the transition of a full curriculum from in-person to virtual during the COVID-19 pandemic while contributing to multiple studies and DSMBs across therapeutic areas.
He holds an M.S. in Medical Physiology from Case Western Reserve University and a B.S. in Exercise Physiology from Texas A&M University.
